Search fresh public links, source activity, and ready-to-use post angles for Mainstay Medical.
Fresh curated links around Mainstay Medical are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
DUBLIN, July 28, 2026 -(BUSINESS WIRE)- Mainstay Medical Holdings plc today announced that Highmark Inc. has established favorable…
Mainstay Medical today announced that Highmark Inc. has established favorable coverage for its ReActiv8 Restorative Neurostimulation therapy.
GALWAY, Ireland, September 2, 2026 – Medtronic (NYSE: MDT), a global leader in healthcare technology announced that the…
The fresh funding will help the business expand to markets outside its established bases in Ireland and the UK, Full Health said. Read more: Irish medtech Full Health Medical raise...
Florence, SC, Aug. 25, 2026 (GLOBE NEWSWIRE) — DeGen Medical, Inc., a U.S.-based medical device manufacturer specializing in patient-specific…
www.lifeafterparalysis.com Twitter: @lifeafterpara Primary research areas Injuries and accidents, Neurological Grant types Project (typically <4 years) Research stages Cl...
Meduloc raises $4 million in a Series B round to bring to market a novel, nitinol based intramedullary fracture fixation system.
Medacta Group SA reports continued above-market revenue growth of 9.7% in c.c.1 in H1 2026 - H1 2026 revenue climbed to Euro 368 million, up 9.7% in c.c.1 or 7.0% in Euro - Sustain...
Record Share Volume Reflects Strong Market Interest in Diversified AI and Revenue-Generating Operations
Medtronic announced that the CMS has granted a New Technology Add-on Payment (NTAP) for INFUSEâ„¢ Bone Graft for TLIF, effective October 1, 2026.
Meduloc’s flexible nitinol intramedullary implant positioned within the bone Financing includes strong support from Pennsylvania investors and former…
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2…
NurExone Biologic Inc., a Frankfurt, Germany-based biotechnology company developing exosome-based regenerative therapies, said Aug. 13 that it and its wholly owned U.S. subsidiary,...
LOS GATOS, CA / ACCESS Newswire / August 28, 2026 / Tenon Medical, Inc. (NASDAQ:TNON), a medical device company dedicated to…
A duodenal mucosal resurfacing procedure may help adults with obesity maintain weight loss 1 year after discontinuing obesity pharmacotherapy, according to topline results from the...
Transaction will bring expandable interbody cage solutions to DePuy Synthes' Spine portfolio to strengthen position across the lumbar fusion market
As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1...
Package Name: Medicine Stocks Recommended Positions: Long Forecast Length: 14 Days (7/16/26 - 7/30/26) I Know First Average: 8.61% Read The Full Forecast...
Package Name: Medicine Stocks Recommended Positions: Long Forecast Length: 14 Days (7/14/26 - 7/28/26) I Know First Average: 8.41% Read The Full Forecast...
Appointment builds on Providence's category leadership in Total Segmental Fusion (TSF)
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.